Home Galapagos, GSK successfully conclude phase 2a study of skin disease drug
 

Keywords :   


Galapagos, GSK successfully conclude phase 2a study of skin disease drug

2014-04-17 09:46:53| Biotech - Topix.net

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

Tags: study skin drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.11 PORTABLE
15.11HG 5R
15.11 ST MAX 5W FLEX S
15.11
15.1189 560 STH
15.11 adidas F50 27.5
15.11 SAMANTHA VEGA
15.1150
More »